Notice of Closed Meeting, 46120 [2020-16671]

Download as PDF 46120 Federal Register / Vol. 85, No. 148 / Friday, July 31, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Notice of Closed Meeting Multi-Agency Informational Meeting To Discuss Reporting Requirements for Entities; Public Webinar [Docket No. CDC–2020–0077; Docket No. NIOSH 338] Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone (513) 533–6800, Toll Free 1(800)CDC– INFO, Email ocas@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)DP21–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Dates: October 6, 2020–October 7, 2020, Panel A; October 8, 2020–October 9, 2020, Panel B Time: 10:00 a.m.–6:00 p.m., EDT Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, JRaman@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–16551 Filed 7–30–20; 8:45 am] [FR Doc. 2020–16671 Filed 7–30–20; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH); Correction Notice is hereby given of a change in the meeting of the Advisory Board on Radiation and Worker Health (ABRWH), NIOSH; August 26, 2020 from 1:15 p.m. to 6:15 p.m., EDT and August 27, 2020 from 1:15 p.m. to 6:30 p.m., EDT, which was published in the Federal Register on July 14, 2020, Volume 85, Number 134, pages 41986–41987. The Matters to be Considered should read as follows: Matters to be Considered: The agenda will include discussions on the following: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; Completed Site Profile Review for W.R Grace Company (Erwin, Tennessee); Update on Site Profile Review for Idaho National Laboratory Site (Burial Ground and other Exposure Scenarios), and Hanford (Richland, Washington); SEC Petition Reviews for Superior Steel (Carnegie, Pennsylvania; 1952–1957), and Reduction Pilot Plant (Huntington, West Virginia; 1976–1978), and a Board Work Session. Agenda items are subject to change as priorities dictate. FOR FURTHER INFORMATION CONTACT: VerDate Sep<11>2014 18:33 Jul 30, 2020 Jkt 250001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Division of Select Agents and Toxins (DSAT) in the Centers for Disease Control, an Operating Division of the Department of Health and Human Services, and the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS), Agriculture Select Agent Services (AgSAS), announce a public webinar to provide guidance regarding the forms used to report or submit information to the Federal Select Agent Program. DATES: The webinar will be held September 23, 2020 from 11 a.m. to 4 p.m. EDT. Participants must register by September 18, 2020. Registration instructions are found on the website, https://www.selectagents.gov. ADDRESSES: This meeting will be held by webinar. FOR FURTHER INFORMATION CONTACT: CDC: Samuel S. Edwin, Ph.D., Director, DSAT, Center for Preparedness and Response, CDC, 1600 Clifton Road NE, MS H–21–7, Atlanta, Georgia 30329. Telephone: (404) 718–2000; email: lrsat@cdc.gov. APHIS: Jack Taniewski, DVM, Director, AgSAS, APHIS, 4700 River Road, Unit 2, Riverdale, MD 20737. Telephone: (301) 851–3300 (option 3); email: AgSAS@ aphis.usda.gov. SUMMARY: The public webinar, scheduled for Wednesday, September 23, 2020, is an opportunity for the affected community and other interested individuals to obtain specific regulatory guidance for the forms used to report or submit information to the Federal Select Agent Program. Representatives from the Federal Select Agent Program, Department of Commerce, Department of Transportation, and the Minnesota Department of Health will be present during the webinar to address questions and concerns from the webinar participants. Participants who want to participate in the webinar should complete their registration online by September 18, 2020. Special instructions will be SUPPLEMENTARY INFORMATION: E:\FR\FM\31JYN1.SGM 31JYN1

Agencies

[Federal Register Volume 85, Number 148 (Friday, July 31, 2020)]
[Notices]
[Page 46120]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)-DP21-001, Pregnancy Risk 
Assessment Monitoring System (PRAMS).
    Dates: October 6, 2020-October 7, 2020, Panel A;
    October 8, 2020-October 9, 2020, Panel B
    Time: 10:00 a.m.-6:00 p.m., EDT
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-16671 Filed 7-30-20; 8:45 am]
BILLING CODE 4163-18-P